164 related articles for article (PubMed ID: 34753870)
61. A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection.
Sneller MC; Justement JS; Gittens KR; Petrone ME; Clarridge KE; Proschan MA; Kwan R; Shi V; Blazkova J; Refsland EW; Morris DE; Cohen KW; McElrath MJ; Xu R; Egan MA; Eldridge JH; Benko E; Kovacs C; Moir S; Chun TW; Fauci AS
Sci Transl Med; 2017 Dec; 9(419):. PubMed ID: 29212716
[TBL] [Abstract][Full Text] [Related]
62. Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques.
Ziani W; Bauer A; Lu H; Wang X; Wu X; Bar KJ; Li H; Liu D; Shaw GM; Veazey RS; Xu H
J Virol; 2021 Apr; 95(9):. PubMed ID: 33568508
[TBL] [Abstract][Full Text] [Related]
63. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption.
Li JZ; Etemad B; Ahmed H; Aga E; Bosch RJ; Mellors JW; Kuritzkes DR; Lederman MM; Para M; Gandhi RT
AIDS; 2016 Jan; 30(3):343-53. PubMed ID: 26588174
[TBL] [Abstract][Full Text] [Related]
64. Initiation of Antiretroviral Therapy during Primary HIV Infection: Effects on the Latent HIV Reservoir, Including on Analytic Treatment Interruptions.
Shelton EM; Reeves DB; Bender Ignacio RA
AIDS Rev; 2020 Oct; 23(1):28-39. PubMed ID: 33105471
[TBL] [Abstract][Full Text] [Related]
65. HIV evolution and diversity in ART-treated patients.
van Zyl G; Bale MJ; Kearney MF
Retrovirology; 2018 Jan; 15(1):14. PubMed ID: 29378595
[TBL] [Abstract][Full Text] [Related]
66. HIV Persistence on Antiretroviral Therapy and Barriers to a Cure.
Sung JM; Margolis DM
Adv Exp Med Biol; 2018; 1075():165-185. PubMed ID: 30030793
[TBL] [Abstract][Full Text] [Related]
67. The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation.
Abrahams MR; Joseph SB; Garrett N; Tyers L; Moeser M; Archin N; Council OD; Matten D; Zhou S; Doolabh D; Anthony C; Goonetilleke N; Karim SA; Margolis DM; Pond SK; Williamson C; Swanstrom R
Sci Transl Med; 2019 Oct; 11(513):. PubMed ID: 31597754
[TBL] [Abstract][Full Text] [Related]
68. Acute HIV-1 infection viremia associate with rebound upon treatment interruption.
Mdluli T; Li Y; Pinyakorn S; Reeves DB; Cardozo-Ojeda EF; Yates A; Intasan J; Tipsuk S; Phanuphak N; Sacdalan C; Colby DJ; Kroon E; Crowell TA; Thomas R; Robb ML; Ananworanich J; de Souza M; Phanuphak P; Stieh DJ; Tomaka FL; Trautmann L; Ake JA; Hsu DC; Francisco LV; Vasan S; Rolland M
Med; 2022 Sep; 3(9):622-635.e3. PubMed ID: 35870446
[TBL] [Abstract][Full Text] [Related]
69. Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.
Puertas MC; Noguera-Julian M; Massanella M; Pou C; Buzon MJ; Clotet B; Stevenson M; Paredes R; Blanco J; Martinez-Picado J
Retrovirology; 2016 Aug; 13(1):51. PubMed ID: 27484989
[TBL] [Abstract][Full Text] [Related]
70. Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation.
Liu PT; Keele BF; Abbink P; Mercado NB; Liu J; Bondzie EA; Chandrashekar A; Borducchi EN; Hesselgesser J; Mish M; Chin G; Bekerman E; Geleziunas R; Barouch DH
Nat Commun; 2020 Oct; 11(1):5412. PubMed ID: 33110078
[TBL] [Abstract][Full Text] [Related]
71. Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals.
Wonderlich ER; Subramanian K; Cox B; Wiegand A; Lackman-Smith C; Bale MJ; Stone M; Hoh R; Kearney MF; Maldarelli F; Deeks SG; Busch MP; Ptak RG; Kulpa DA
PLoS Pathog; 2019 Oct; 15(10):e1008074. PubMed ID: 31609991
[TBL] [Abstract][Full Text] [Related]
72. Immunological and virological findings in a patient with exceptional post-treatment control: a case report.
Climent N; Ambrosioni J; González T; Xufré C; Casadellà M; Noguera-Julian M; Paredes R; Plana M; Grau-Expósito J; Mallolas J; Alcamí J; Sánchez-Palomino S; Miró JM;
Lancet HIV; 2023 Jan; 10(1):e42-e51. PubMed ID: 36354046
[TBL] [Abstract][Full Text] [Related]
73. Persistent HIV-1 transcription during ART: time to reassess its significance?
Fombellida-Lopez C; Berkhout B; Darcis G; Pasternak AO
Curr Opin HIV AIDS; 2024 May; 19(3):124-132. PubMed ID: 38502547
[TBL] [Abstract][Full Text] [Related]
74. Multidrug-resistant HIV viral rebound during early syphilis: a case report.
Giacomelli A; Micheli V; Cattaneo D; Mancon A; Gervasoni C
BMC Infect Dis; 2020 Apr; 20(1):273. PubMed ID: 32264923
[TBL] [Abstract][Full Text] [Related]
75. In Vivo Dynamics of the Latent Reservoir for HIV-1: New Insights and Implications for Cure.
Siliciano JD; Siliciano RF
Annu Rev Pathol; 2022 Jan; 17():271-294. PubMed ID: 34736342
[TBL] [Abstract][Full Text] [Related]
76. Measuring HIV Persistence on Antiretroviral Therapy.
Horsburgh BA; Palmer S
Adv Exp Med Biol; 2018; 1075():265-284. PubMed ID: 30030797
[TBL] [Abstract][Full Text] [Related]
77. HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.
Omondi FH; Sudderuddin H; Shahid A; Kinloch NN; Jones BR; Miller RL; Tsai O; MacMillan D; Trocha A; Brockman MA; Brumme CJ; Joy JB; Liang R; Walker BD; Brumme ZL
mBio; 2021 Dec; 12(6):e0249021. PubMed ID: 34781741
[TBL] [Abstract][Full Text] [Related]
78. HIV-1 DNA and RNA kinetics in primary HIV infection.
Lillo F; Grasso M; Lodini S; Capiluppi B; Lazzarin A; Tambussi G
J Biol Regul Homeost Agents; 2002; 16(1):49-52. PubMed ID: 12003174
[TBL] [Abstract][Full Text] [Related]
79. Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir.
Calin R; Hamimi C; Lambert-Niclot S; Carcelain G; Bellet J; Assoumou L; Tubiana R; Calvez V; Dudoit Y; Costagliola D; Autran B; Katlama C;
AIDS; 2016 Mar; 30(5):761-9. PubMed ID: 26730568
[TBL] [Abstract][Full Text] [Related]
80. Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.
Palesch D; Bosinger SE; Mavigner M; Billingsley JM; Mattingly C; Carnathan DG; Paiardini M; Chahroudi A; Vanderford TH; Silvestri G
J Virol; 2018 Jul; 92(14):. PubMed ID: 29720521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
